ONCOLYTIC CLOSTRIDIUM GHONII STRAINS, METHODS OF PRODUCTION AND USE Russian patent published in 2018 - IPC C12N1/20 A61K35/74 A61K39/08 A61P35/00 C12R1/145 

Abstract RU 2667432 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to bacterial strains Clostridium ghonii capable of suppressing the growth of, regressing or destroying solid tumours, as well as to use thereof. Proposed are strains Clostridium ghonii MW-DCG_HNCv18, Clostridium ghonii MW-DCG_CCv17 and Clostridium ghonii MW-DCG_LCv26, deposited in the National Measurement Institute (National Measurement Institute, 1/153 Bertie Street, Port Melbourne, Victoria, Australia 3207) under the appropriate registration numbers V12/001485, V12/001487 and V12/001486. Proposed strains are used to suppress the growth of a solid tumour, regressing or destroying thereof in a subject, for treating such a tumor in a subject, for preparing a medicament for treating a solid tumour. Proposed strains can also be used to suppress or treat a solid tumour as part of a pharmaceutical composition or as part of a kit.

EFFECT: proposed are oncolytic Clostridium ghonii strains, and methods of production and use.

47 cl, 11 dwg, 3 tbl, 3 ex

Similar patents RU2667432C2

Title Year Author Number
CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE 2014
  • Ekl Charlz
  • Grendzh Dzhon
  • Bilyard Kevin
RU2719934C2
METHOD OF TREATING CANCER (VERSIONS) 2006
  • Kun Ehrnest Kun
  • Mendeleev Dzherom
  • Behsbom Kehrol
  • Lemdzhabbar-Alaui Khassan
  • Ossovskaja Valerija
RU2447889C2
ANTI-TUMOUR AGENT BASED ON RECOMBINANT VACCINIA VIRUS STRAIN AND METHOD FOR PRODUCTION THEREOF 2019
  • Kuligina Elena Vladimirovna
  • Koval Olga Aleksandrovna
  • Rikhter Vladimir Aleksandrovich
  • Kochneva Galina Vadimovna
  • Sivolobova Galina Filippovna
  • Grazhdantseva Antonina Anatolevna
  • Troshkova Galina Pavlovna
RU2730657C1
MONOCLONAL ANTIBODIES FOR TUMOUR TREATMENT 2009
  • Rotem-Jekhudar Rinat
  • Rodionov Galina
RU2531758C2
METHODS OF TREATING CANCER, HAVING HEMIZYGOUS LOSS OF TP53 2016
  • Liu, Yunhua
  • Lu, Xiongbin
RU2721953C2
IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT 2019
  • Puisis, John
RU2794261C2
BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS 2017
  • Kezada, Serkhio
  • Peggs, Karl
  • Arse Vargas, Frederik
RU2759970C2
DUOCARMICIN ADC SHOWING IMPROVED ANTI-TUMOUR ACTIVITY IN VIVO 2015
  • Dokter Villem
  • Besker Patrik Khenri
  • Gudings Peter Jokhannes
  • Verkhejden Gejsbertus Fransiskus Mariya
RU2689779C2
DUOCARMYCIN ADCs EXHIBITING IMPROVED ANTI-TUMOUR ACTIVITY IN VIVO 2015
  • Dokter, Villem
  • Gudings, Peter Jokhannes
  • Verkhejden, Gejsbertus Fransiskus Mariya
  • Besker, Patrik Khenri
RU2769700C2
TREATMENT OF CANCER, USING ANTIBODY TO SEMAPHORIN 4D IN COMBINATION WITH EPIGENETIC MODULATING AGENT 2018
  • Evans, Elizabet
  • Smit, Ernest S.
  • Zauderer, Moris
RU2783535C2

RU 2 667 432 C2

Authors

Vej Min

Dates

2018-09-19Published

2013-04-29Filed